BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+0.42%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.2B
AUM Growth
+$1.2B
(-8.8%)
Cap. Flow
-$29.9M
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
STAAR Surgical
STAA
|
$9.27M |
Top Sells
| 1 |
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
|
$39.2M |
Sector Composition
| 1 | Healthcare | 39.84% |
| 2 | Consumer Staples | 39.54% |
| 3 | Industrials | 10.55% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $473M | 39.54% | 4,656,488 | – | – |
|
|
2
STAAR Surgical
STAA
$1.36B
| $426M | 35.66% | 8,783,082 +191,075 | +2% | +$9.27M |
|
3
Axon Enterprise
AXON
$58.7B
| $126M | 10.55% | 760,062 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $120M | 10.06% | 690,000 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $40.9M | 3.42% | 34,935,485 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $7.49M | 0.63% | 23,353,697 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $1.65M | 0.14% | 2,997,156 | – | – |
|
|
BTRS
8
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| – | – | -4,229,652 | Closed | -$39.2M |
|